Gonorrhoea Vaccine: UK as the First Country to Offer 4CMenB for Gay Men
Gonorrhoea Vaccine in the UK and How Effective is it?
A new chapter in sexual health begins - and it starts in the UK. For the first time, a vaccine built for meningitis might just be protecting against gonorrhoea too.
England has become the first country in the world to start offering a meningococcal B vaccine (4CMenB) as part of a targeted programme to protect against gonorrhoea. While originally designed to prevent meningitis, research has shown that the jab also provides some protection (approx. 40%) against Neisseria gonorrhoeae, the bacterium that causes gonorrhoea (likely due to shared antigens between N. meningitidis and N. gonorrhoeae). Let's learn more about gonorrhoea prevention in gay men.
To learn more about STI-s, this blog gives you clear, practical, and stigma-free sexual health guidance so you can explore your desires with confidence and stay in control of your wellbeing.
Who Can Get the Gonorrhoea Vaccine in the UK Right Now?
The programme is currently focused on men who have sex with men (MSM), a group considered to be at higher risk of infection. The goal is to test how effective the vaccine is in the real world, how long protection lasts, and whether it is a cost-effective strategy for broader use. Early results will guide whether the vaccine is offered more widely.
Read more about this program from the official source:
https://www.gov.uk/government/news/nhs-begins-rollout-of-world-first-gonorrhoea-vaccine-programme
Global Interest: Which Countries May Follow the UK
Other countries are closely watching England’s lead. Health authorities in Australia, New Zealand, and parts of Europe are reviewing evidence and considering similar trials or pilot programmes (such as this one).
For individuals, 4CMenB (marketed as Bexsero) is available privately in 58 countries. It is important to remember that other countries do not offer this solution officially yet - it is still used for the prevention of meningitis, and using it to prevent gonorrhoea would be an example of off-label use and would definitely require a consultation with a doctor. Nevertheless, the fact that the vaccine already exists (first licensed in 2013) reduces doubts regarding its safety - it is a well-studied preparation with properly described potential side effects (see the Prescribing Information guide).
Find out more from these publications. All are from 2025:
Effectiveness of menb-4C vaccine against gonorrhoea
Meningococcal vaccines show effectiveness in gonorrhoea prevention
The United Kingdom meningococcal vaccine (4CMenB) programme against gonorrhoea
How 4CMenB Works, Why It Shows Protection Against Gonorrhoea
4CMenB was originally developed to protect against meningococcal disease, but the vaccine also targets several antigens that are shared between Neisseria meningitidis and Neisseria gonorrhoeae. These shared proteins, including NHBA and fHbp, trigger an immune response that appears to offer partial cross-protection against gonorrhoea. When someone receives the 4CMenB vaccine, their immune system produces antibodies that recognise these antigens. Although the match is not perfect, the antibodies can still reduce the likelihood of gonorrhoea infection and may lower bacterial load in breakthrough cases. This is why real-world studies show Bexsero gonorrhoea protection at approximately 30 to 40 percent, even though the vaccine was never designed specifically for gonorrhoea. Ongoing research in the UK rollout will help determine how strong this protection is, how long it lasts, and whether booster doses could improve effectiveness in high-risk sexual networks.
Key Takeaways
This marks the first real-world rollout of an existing vaccine to curb gonorrhoea infections - a major step in the fight against one of the world’s most stubborn and antibiotic-resistant sexually transmitted infections.
Even though the effectiveness of this vaccine could be higher (although the current rollout will look into it closer), this is amazing news - every little helps if it comes to health protection.
Sexual health interventions matter most when they support real-life sexual behaviour and identity.
The 4CMenB rollout is a reminder that owning your sexual health is just another way to own your power. Whether you’re gearing up in latex, leather, or nothing at all, protection starts with confidence - and confidence looks damn good on you. If you’re eligible, talk to your clinic about getting the vaccine and keep your play as fearless as your style. Smart, sexy, and protected, that’s the real fantasy.